中轴型脊柱关节炎患者椎体及脊柱后部结构炎症与结构变化的MRI评估:基于解剖的CANDEN评分系统在随机安慰剂对照试验中的结构效度、反应性和区分能力
研究基于49例中轴型脊柱关节炎患者随机安慰剂对照试验的脊柱MRI,评估CANDEN评分系统的信度、反应性和区分能力。CANDEN脊柱炎症评分反应性高(Guyatt指数1.88),与SPARCC指数相似,第6周即可区分阿达木单抗与安慰剂(P=0.03)。结构评分横断面信度好,但变化评分信度差。
要点
- CANDEN脊柱炎症评分反应性高,第6周可区分阿达木单抗与安慰剂(P=0.03)。
- CANDEN炎症与脂肪评分信度好至很好(ICC=0.71-0.92)。
- CANDEN新骨形成与骨侵蚀评分横断面信度好至很好(ICC=0.61-0.75),变化评分信度差(ICC≤0.40)。
核心结论
- CANDEN脊柱炎症评分显示良好的反应性、区分积极治疗与安慰剂的能力及信度。
- CANDEN脊柱结构评分具有好的横断面信度,但需要更长期的研究来探究其变化敏感性。
研究设计与样本
- 研究纳入49例中轴型脊柱关节炎患者,来自研究者发起的阿达木单抗随机安慰剂对照试验,于第0/6/24/48周行脊柱MRI。
- MRI图像按CANDEN系统和加拿大脊柱关节炎研究联盟(SPARCC)方法评分,总评分及各种子评分由各病灶评分相加得出。
主要发现
- CANDEN脊柱炎症评分反应性高,与SPARCC脊柱MRI指数相似(Guyatt反应性指数分别为1.88和1.67)。
- CANDEN脊柱炎症评分在第6周随访时即可区分阿达木单抗与安慰剂治疗(P=0.03)。
- 前/后角炎症子评分显示相似的反应性。
- CANDEN脊柱炎症和脂肪评分的读者间信度在状态和变化评分均为好至很好(组内相关系数ICC=0.71-0.92)。
- CANDEN新骨形成和骨侵蚀评分的信度在状态评分为好至很好(ICC=0.61-0.75),但因进展极小,变化评分信度差(ICC≤0.40)。
关键数值与推荐
- CANDEN脊柱炎症评分的Guyatt反应性指数为1.88,SPARCC脊柱MRI指数为1.67。
- CANDEN脊柱炎症评分区分阿达木单抗与安慰剂的P=0.03。
- CANDEN炎症和脂肪评分的ICC=0.71-0.92。
- CANDEN新骨形成和骨侵蚀状态评分的ICC=0.61-0.75,变化评分ICC≤0.40。
局限性
- 因进展极小,CANDEN新骨形成和骨侵蚀变化评分信度差(ICC≤0.40)。
- 需要更长期的研究来探究结构评分的变化敏感性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Canada-Denmark (CANDEN) definitions of spinal MRI lesions allow a detailed anatomy-based evaluation of inflammatory and structural lesions in vertebral bodies and posterior elements of the spine in patients with axial spondyloarthritis (axSpA). The objective was to examine the reliability, responsiveness and discrimination of scores for spinal inflammation, fat, bone erosion and new bone formation based on the CANDEN system and to describe patterns of inflammatory and structural lesions and their temporal development. METHODS: 49 patients with axSpA from an investigator-initiated, randomised, placebo-controlled trial of adalimumab underwent spinal MRI at weeks 0/6/24/48. MR images were scored according to the CANDEN system and the Spondyloarthritis Research Consortium of Canada (SPARCC) method. Total scores, and various subscores, were created by summing individual lesion scores. RESULTS: The CANDEN spine inflammation score had high responsiveness, similar to the SPARCC MRI spine index (Guyatt's responsiveness index 1.88 and 1.67, respectively), and discriminated between adalimumab and placebo treatment already at 6 weeks' follow-up (P=0.03). Anterior/posterior corner inflammation subscores showed similar responsiveness. Inter-reader reliability for the CANDEN spine inflammation and fat scores was good to very good for status and change scores (intraclass correlation coefficient (ICC)=0.71-0.92). Reliability for CANDEN new bone formation and erosion scores was good to very good for status scores (ICC=0.61-0.75) but, due to minimal progression, poor for change scores (ICC≤0.40). CONCLUSIONS: The CANDEN spine inflammation score showed good responsiveness, discrimination between active treatment and placebo and reliability. The CANDEN spine structural scores had good cross-sectional reliability, but longer studies are needed to investigate their sensitivity to change. TRIAL REGISTRATION NUMBER: NCT01029847; Results.
引用
- Krabbe S, Sørensen IJ, Jensen B, et al. Inflammatory and structural changes in vertebral bodies and posterior elements of the spine in axial spondyloarthritis: construct validity, responsiveness and discriminatory ability of the anatomy-based CANDEN scoring system in a randomised placebo-controlled trial. RMD Open. 2018. PMID: 29556419. doi:10.1136/rmdopen-2017-000624
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。